Clinical trials
Withdrawn Cholangiocarcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Kejing Biotechnology Co., Ltd. | 1 |
| City of Hope Medical Center | 1 |
| Emory University | 1 |
| Fudan University | 1 |
| Galectin Therapeutics Inc. | 1 |
| Geneplus-Beijing Co. Ltd. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Jordan Kharofa | 1 |
| Kwang Hyuck Lee | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 32 |
| Pancreatic Neoplasms | 7 |
| Carcinoma, Hepatocellular | 6 |
| Breast Neoplasms | 4 |
| Gallbladder Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Lung Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.